Californian Covid-19 victim who test positive for the Omicron virus, which causes the disease, was fully immunized. He has been improving since Wednesday, U.S. Health officials stated.

Although the patient had been otherwise healthy upon their return to San Francisco Bay after traveling in South Africa Nov. 22, they developed symptoms three day later. They were diagnosed with Covid and received a positive test on November 29, California health officials reported.

At the University of California San Francisco, scientists obtained the patient’s DNA Tuesday at around 3:00 PM Pacific. They completed sequencing within five hours.

Gov. Gavin Newsom said Wednesday that the patient was between 18-49 years old and hadn’t had a booster shot since they weren’t six months away from their first vaccination.

Newsom confirmed that this individual had not been admitted to a hospital. Newsom stated that no positive tests have been performed on the individuals this individual came into contact with. We believe this individual will be fully recovered and are optimistic based upon what we know.

The Centers for Disease Control and Prevention recommends that all U.S. adults get a booster six months after their original Pfizer or Moderna two-dose course, and two months after their single J&J shot.

Dr. Mark Ghaly,  California’s Health and Human Services secretary, said the fact that the patient is improving underscores the importance of vaccination.

Ghaly said that the vaccinations “protect against severe diseases, hospitalization, and death” after months of discussions. Newsom was also present at Ghaly’s briefing. It is becoming clearer that individuals with Omicron are not suffering severe symptoms as a result of sequencing. This is, in my opinion, a testament to the importance and effectiveness of vaccines.

Ghaly stated that there is still much to know about this variant but encouraged Californians get vaccinated.

On Wednesday, Dr. Anthony Fauci, White House chief medical adviser, said to reporters that although the mutation profile for the Omicron variant indicates it could affect the effectiveness of vaccines on the market currently available on the market (but more data are needed).

Fauci stated Wednesday that the molecular profiles of different mutations (in omicron), would indicate that the virus might be more easily transmissible, and might not receive some vaccine protection. We don’t yet know the answer.

Moderna CEO and Pfizer CEO have stated that it will take around two weeks to assess how much omicron has an effect on the effectiveness the existing vaccines.

Albert Bourla, CEO of Pfizer, said that he doesn’t believe the outcome will be vaccines don’t protect. told CNBC on Monday. “I believe the outcome could be, but we don’t yet know, that the vaccines protect less.

Bourla claimed that Pfizer has the ability to develop new vaccines in less than 100 days. He said that the company could quickly develop vaccines against beta and delta Covid variations, but they were not used because the original vaccine was still effective.

Stephane Bancel, CEO of Moderna, said that the vaccine manufacturer can quickly roll out higher dose booster shots but could take longer. take until early 2022To develop and deliver a shot specifically targeting omicron.

Bancel stated that while the higher dosage could be achieved immediately, it would take months for an omicron-specific variant to be ready for shipping in large quantities.Squawk Box” Monday.

Maria Van Kerkhove is the World Health Organization’s Covid technical leader. She said that reports from South Africa suggest some people infected by omicron have mild symptoms but others are more severely affected. Van Kerkhove stated that studies will be looking into those who have been hospitalized in order to determine if the patient has the omicron variant.

It is likely that the virus will continue to evolve and become more transmissible than Delta. We’ll need to wait to find out,” she stated. We don’t yet know the degree of severity.